Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Coming Clean

By Pharmaceutical Processing | March 8, 2010

Is it just me, or have we entered a time where corporate scandals, and larger than life “falls from grace” are increasing common? Lately, it seems more and more sports figures, politicians, and major companies are getting caught in either illegal or immoral activities or the intentional withholding of important information – only to have their actions and misdeeds eventually revealed by the media, or other sources. This revelation is usually followed by a very public “mea culpa” with the accused holding a press conference, or appearing before Congress and admitting their mistakes and/or transgressions and promising to make things “right”.

I have conveniently broken these down into three categories, with examples:

1. The sports figure accused of steriod use – the subsequent denial of such use – then the admission and apology. Example: Alex Rodriguez

2. The politician accused of extramarital infidelity – the subsequent denial – then the admission and apology. Example: John Edwards

3. The major corporation accused of suppressing important safety information – the subsequent stalling – then the admission and apology. Example: Toyota

Nothing like this would ever happen to a pharmaceutical company now would it?

We are now in the midst of GSK’s very public problems relating to Avandia. Basically, the problems revolve around a report that accused the drug company of withholding information about side effects of serious heart problems, including death. At issue now is whether Avandia should be taken off the market.

Should GSK come clean and let the world know what it knew and when it knew it?

Based on similar transgressions – its the first step on the road to recovery.

 

Related Articles Read More >

FDA logo
FDA prevented 317 drug shortages in 2021
Pfizer-BioNTech vaccine vial
Pfizer, BioNTech moving forward on seeking COVID-19 vaccine EUA for youngest children
FDA logo
FDA curtails use of Janssen COVID-19 vaccine over blood clotting concerns
FDA logo
FDA sends warning letters to CBD and delta-8 THC product vendors

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards